Briefs: Link Pharma Chem and Zydus
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Subscribe To Our Newsletter & Stay Updated